Skip to main content
. 2022 Mar 3;9:772048. doi: 10.3389/fmed.2022.772048

Table 1.

Baseline characteristics of donor and recipients.

Characteristics n = 778
Donor
Age (yr) 48.8 (40.6–56.9)
Gender, male 652 (83.8%)
Steatosis
No 576 (74.0%)
Mild 173 (22.2%)
Moderate 29 (3.7%)
Donation type, DCD 304 (39.1%)
BMI (kg/m2) 22.8 (21.1–24.5)
Graft weight (g) 1,360 (1,205–1,560)
GRWR (%) 2.06 (1.77–2.44)
HB (g/dl) 11.1 (8.9–13.6)
WBC (×109/L) 12.4 (9.4–16.3)
PLT (×109/L) 147 (96–222)
Na (mmol/L) 145 (138–152)
K (mmol/L) 4.0 (3.7–4.5)
Bun (mmol/L) 7.4 (5.2–10.0)
Cr (μmol/L) 83 (59–128)
ALT (U/L) 38 (24–73)
AST (U/L) 56 (36–89)
ALB (g/L) 33 (29–37)
GGT (U/L) 50 (24–95)
ALP (U/L) 83 (64–111)
TB (μmol/L) 15.3 (10.5–21.6)
Recipient
Age (yr) 50 (42–57)
Gender, male 653 (83.9%)
BMI (kg/m2) 23.0 (21.2–25.3)
Liver disease etiology
Hepatitis B 599 (77.0%)
Hepatitis C 31 (4.0%)
Alcoholic 94 (12.1%)
Autoimmune 36 (4.6%)
Other 56 (7.2%)
MELD score 35 (32–40)
CP score 11 (10–12)
Waiting time (d) 34 (26–57)
Follow-up time (d) 534 (238–753)
Perioperative
Operative time (h) 5.2 (4.5–6.5)
Anhepatic phase (min) 60 (46–77)
WIT (min) 4 (2–8)
CIT (h) 8.2 (7.2–10.7)
ABO blood type in compatible 151 (19.4%)
Intraoperative blood loss (ml) 1,000 (800–1,800)
Intraoperative blood transfusion (U) 4 (2–8)